Mar 20, 2026

Email 1:

Subject: 6 Days to Go: Here’s What You Can’t Miss at the Healthcare Asia Summit Next Week

Summary: The Healthcare Asia Summit is just six days away, offering an important event for healthcare leaders to explore the latest innovations and solutions. Complimentary passes are available for healthcare leaders, while solution providers and non-healthcare professionals can purchase tickets. Attendees can access the agenda, register online, and benefit from key sessions and networking opportunities designed to enhance healthcare delivery in Asia. Don’t miss the chance to be part of this crucial event.

Sender: healthcareasia@cmgnewsletter.comD

Email 2:

Subject: Did we undercount Covid deaths by 155,000?

Summary: A new AI analysis suggests the official U.S. COVID-19 death toll for 2020-2021 might be undercounted by approximately 155,000 deaths, mostly among Hispanic and other people of color in southern and southwestern states. The data highlights significant discrepancies in pandemic mortality reporting. The newsletter also covers challenges in NIH-funded science as many federally funded researchers are scaling back work due to budget cuts and uncertainties. In addition, new vaccine recommendations from WHO, concerns about Medicaid fraud impact on people with disabilities, and research linking premature menopause to heart disease risk are discussed, alongside updates on controversial hepatitis B vaccine trials.

Sender: newsletter@statnews.comD

Email 3:

Subject: 🏛️ Abortion pill anxietys

Summary: Senator Josh Hawley has introduced a bill to ban the abortion drug mifepristone, stirring debate within the GOP just before midterm elections. The bill reflects frustration over the pace of FDA safety investigations and pressures on the Trump administration. Anti-abortion groups criticize the administration for defending mifepristone in courts, generating tension among Republicans. Additionally, an Axios-Ipsos survey shows rising use of GLP-1 weight-loss drugs, but most Americans remain uninterested or worried about side effects, not cost. A new JAMA Psychiatry review finds psychedelic-assisted therapy may be no more effective than traditional antidepressants for depression. The newsletter includes discussions on Medicare Advantage payments and recent health policy news.

Sender: vitals@axios.comD

Email 4:

Subject: Ending soon, last chance to get STAT+ for 50% off

Summary: STAT+ is offering a limited-time 50% discount on annual subscriptions, reducing the price to $199.50 for one year (regularly $399). This subscription provides access to premium biotech, pharma, and life science industry news and analysis. The promotion ends tonight at midnight. Subscribers can cancel anytime and use code MARCH2026 at checkout to activate the offer.

Sender: marketing@statnews.comD

Email 5:

Subject: ☕ Join Axios March 26 | Coffee & convos on the future of health care costs feat. Sen. Lisa Blunt Rochester, Rep. Adrian Smith

Summary: Axios invites healthcare leaders to a live conversation event in Washington D.C. on March 26, 2026, focused on exploring the drivers of healthcare costs including hospital pricing, prescription drugs, and system complexity. The event features key policymakers including Senator Lisa Blunt Rochester and Representative Adrian Smith, along with industry experts. Attendees will enjoy breakfast, networking, and moderated discussions about improving affordability, transparency, and accountability in healthcare. The event runs from 7:30 to 9:00 AM ET at The Showroom, 1099 14th St NW.

Sender: events@axios.comD

Email 6:

Subject: Static electricity is still a mystery — here’s what we knows

Summary: This scientific briefing examines the long-standing mystery of static electricity, exploring recent research revealing how materials remember past contacts that influence charge transfer. It also highlights breakthroughs such as CRISPR–Cas9 gene-editing used to engineer cancer-fighting immune cells inside mice, new findings on the effects of contact sports on brain barriers leading to cognitive decline, the awarding of the Abel Prize to mathematician Gerd Faltings, and discoveries rewriting the history of “magic mushrooms.” Additionally, emerging insights on GLP-1 weight-loss pills and a cautionary note on AI’s reliability in climate modeling are included. The newsletter provides detailed articles and expert commentary for scientific readers.

Sender: briefing@nature.comD

Stay Well!